2009 annual financial data
Anika Therapeutics 2009 Operating margin
Direct answer
Operating margin was 13.92%.
Operating income was 5,586,739 USD and net income was 3,687,567 USD.
Operating cash flow was 3,094,705 USD.
Get free Anika Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 40,135,704 USD
- Operating income
- 5,586,739 USD
- Net income
- 3,687,567 USD
- Operating cash flow
- 3,094,705 USD